<?xml version="1.0" encoding="UTF-8"?>
<p>After screening, eligible patients will undergo a predefined reduction of immunoglobulin or corticosteroids over a maximum of 12â€‰weeks or until deterioration (washout phase). Immunoglobulin doses will be reduced by 25% at each sequential infusion, and corticosteroids will be reduced as per investigator discretion.</p>
